Cleanspace Holdings Ltd. · ASX:CSX
Cleanspace — FY2026 Earnings Presentation
21 slides from Cleanspace's earnings presentation, Aug 28, 2026
Slide 1: FY26 Results Presentation
For personal use only CleanSpace® Holdings Ltd FY26 Results Presentation 28 August 2026
Slide 2: Important Notice & Disclaimer
IMPORTANT NOTICE & DISCLAIMER For personal use only ACCEPTANCE FINANCIAL DATA This presentation has been prepared by CleanSpace Holdings Limited (ACN 150 214 636) (CleanSpace). CleanSpace’s financial results are reported under International Financial Reporting Standards (IFRS). By accepting, accessi
Slide 3: Presenters
Presenters For personal use only Graham McLean Gabrielle O’Carroll Bree Greeff Chairman Chief Executive Officer Chief Financial Officer 3
Slide 4: Our vision and mission
Our vision is to redefine respiratory protection world-wide by empowering every worker in high-risk environments to breathe freely, safely, and confidently—anytime, anywhere. Our mission is to be committed to continuous innovation and the development of respirators that offer superior quality, are e
Slide 5: About CleanSpace Technology
About CleanSpace Technology For personal use only CleanSpace Technology is a Sydney-based company that designs advanced respiratory protection for people working in tough industrial environments. Australian exporter with a track record in six focus Product Category markets • Respiratory Safety • Pow
Slide 6: Financial Summary
For personal use only Financial Summary Revenue Regional Performance FY26 Snapshot • Revenue of $19.8M, +0.3% v PCP, demonstrated resilience amid $19.8M Europe +8% APAC & ROW -0.2% increased macro-economic uncertainty, a changing regulatory North America -29% environment and impact on product launch
Slide 7: Performance Against FY26 Objectives
Performance Against FY26 Objectives For personal use only FY26 Objectives FY26 Delivery Progress 0.3% Revenue growth Europe +8%: Western Europe +16%, Nordics +12%, Eastern Europe +150% 20% Revenue growth APAC & ROW flat v PCP: A/NZ regulatory transition; SE Asia +76% despite Indonesian landslide Nor
Slide 8: Regional Sales Trends
Regional Sales Trends For personal use only Europe FY26 Revenue by Region • Revenue +8%, led by Western Europe (+16%), the Nordics (+12%) and Eastern Europe (+150%) • Repeat business in France and the Nordics offset UK regulatory $2.2M disruption and DACH softness APAC & ROW 11% • Revenue broadly st
Slide 9: CleanSpace AGILE – now certified and selling into market
CleanSpace AGILE – now certified and selling into market For personal use only Two loose-fitting certifications built on our proprietary AirSensit® breath-responsive technology • EN 12941:2023 (TH) in Europe • AS/NZS 17420.2:2021 in Australia/New Zealand AGILE is the first PAPR to receive an A/NZ ce
Slide 10: FY26 Financials
For personal use only FY26 Financials
Slide 11: Summary P&L
Summary P & L For personal use only Revenue steady; profit lifted by a non-cash gain Movement $M FY2026 FY2025 % Revenue steady at $19.8M; gross margin held at 75% • Revenue up 0.3% to $19.8M, as growth in Europe offset a decline in North Revenue 19.8 19.8 0.3 America • Gross margin held at 75%, con
Slide 12: Statement of Financial Position
Statement of Financial Position For personal use only A strong balance sheet funding continued investment in growth FY2026 FY2025 Movement $M % • Cash (including term deposits) decreased 4% to $10.1 million, from Cash and cash equivalents 10.1 10.5 (4) $10.5 million v PCP • reflecting continued inve
Slide 13: Statement of Cashflow
Statement of Cashflow For personal use only FY2026 FY2025 Movement $M % Cash flows from operating activities Receipts from customers 19.8 19.1 4 Payments to suppliers and (20.8) (18.9) (10) • Net cash from operating activities was $(0.1)M (FY25: $1.1M), employees reflecting flat revenue and continue
Slide 14: Strategy & Outlook
For personal use only Strategy & Outlook
Slide 15: FY27 Strategy
FY27 Strategy For personal use only Our Vision: to redefine respiratory protection world-wide Empowering every worker in high-risk environments to breathe freely, safely, and confidently - anytime, anywhere. GROWTH INNOVATION EXCELLENCE Achieve operational efficiency and quality Expand revenue throu
Slide 16: Medium Term Outlook
Medium Term Outlook For personal use only FY27 OBJECTIVES • AGILE commercialisation. Drive increased market share in the UK and Australia/New Zealand 20%+ by expanding CleanSpace’s addressable market across a broader range of users • Distribution to revenue. Leverage the distributor and agency netwo
Slide 17: Thank you
For personal use only CleanSpace Holdings Ltd. Thank you secretary@cleanspacetechnology.com
Slide 18: Appendix
18 For personal use only APPENDIX
Slide 19: Statement of Profit or Loss and Other Comprehensive Income
Statement of Profit or Loss and Other Comprehensive Income For the year ended 30 June 2026 ¢ Revenue from the sale of goods and services, Revenue from the sale of goods and services, 3 19822,058 19764764 (oe) Cost of sales 6.028.293) age906n Gross profit 14793765 1475703 cab) Other income 234 33.874
Slide 20: Statement of Financial Position
Statement of Financial Position As at 30 June 2026 > paws Current assets Cc Cash and cash equivalents 7 were 2520183 Trade and other receivables 8 asoose7 4257626 Inventories 2 2227202 «(2.254228 Other assets 0 ‘331207 394078 Financial esceta 2 2.305150 7984328 Income tax receivable 8 938005 or095s
Slide 21: Statement of Cash Flows
Statement of Cash Flows For the year ended 30 June 2026 ‘Cash flows from operating activities Receipts from customers (inclusive of GST) 19,840,912 19133226 Payments to suppliers and employees (inclusive of GST) (20,784,320) (18,946,180) (943,408) 187,046 Interest and other finance costs paid (618)